3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
4
Completed
2
Active not recruiting
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
51
Multiple Myeloma
25
Myelodysplastic Syndromes
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Leukemia
23
Lymphoma
22
Lymphoma, Non-Hodgkin
21
Leukemia, Lymphocytic, Chronic, B-Cell
21
Melanoma
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Neoplasms
13
Hodgkin Disease
13
Neoplasm Metastasis
12
Recurrence
11
Hematologic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
9
Skin Neoplasms
8
Neoplasms, Plasma Cell
8
Lymphoma, Mantle-Cell
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
8
Kidney Neoplasms
8
Ovarian Neoplasms
7
Myeloproliferative Disorders
7
Carcinoma, Non-Small-Cell Lung
7
Burkitt Lymphoma
7
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Primary Myelofibrosis
5
Anemia, Refractory, with Excess of Blasts
5
Interventions
Doxorubicin
13
Gemcitabine
10
Cyclophosphamide
10
pazopanib
8
Filgrastim
8
Radiotherapy
7
Ifosfamide
7
Cisplatin
7
Irinotecan
6
Docetaxel
6
Radiation
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Trabectedin
4
Magnetic Resonance Spectroscopy
4
Celecoxib
4
Busulfan
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
temsirolimus
3
sargramostim
3
pembrolizumab
3
X-Rays
3
Sirolimus
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Neoadjuvant Therapy
3
Leucovorin
3
Dexrazoxane
3
Cryosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Sarcoma
×
fludarabine
×
Clear all
NCT03240861
2023-11-01
NYESO SCT
Jonsson Comprehensive Cancer Center
Phase 1
Terminated
5 enrolled